A cassette vector for the construction of antigen chimaeras of poliovirus.

A cassette vector has been constructed which allows the rapid and extensive modification of one of the neutralizing antigenic sites of the Sabin 1 poliovirus vaccine strain, P1/LSc 2ab. Unique restriction endonuclease sites flanking antigenic site 1 have been engineered into a full-length infectious Sabin 1 cDNA clone with minimal alteration to the coding sequence. This facilitates replacement of this region by oligonucleotides encoding foreign amino acid sequences. Our results indicate that this region is highly flexible in terms of the number and sequence of amino acids which can be accommodated.

[1]  C. Wychowski,et al.  Engineering a poliovirus type 2 antigenic site on a type 1 capsid results in a chimaeric virus which is neurovirulent for mice. , 1988, The EMBO journal.

[2]  D. Filman,et al.  Three-dimensional structure of poliovirus serotype 1 neutralizing determinants , 1988, Journal of virology.

[3]  E. Wimmer,et al.  Poliovirus type 1/type 3 antigenic hybrid virus constructed in vitro elicits type 1 and type 3 neutralizing antibodies in rabbits and monkeys. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[4]  G. Dunn,et al.  Antigen chimaeras of poliovirus as potential new vaccines , 1988, Nature.

[5]  G. Werner,et al.  Different rhinovirus serotypes neutralized by antipeptide antibodies , 1987, Nature.

[6]  R. Rico-Hesse,et al.  Geographic distribution of wild poliovirus type 1 genotypes. , 1987, Virology.

[7]  P. Minor,et al.  The complete nucleotide sequence of coxsackievirus B4 and its comparison to other members of the Picornaviridae. , 1987, The Journal of general virology.

[8]  S. Reed,et al.  Reactivity of anti-peptide and anti-poliovirus type 3 monoclonal antibodies with synthetic peptides. , 1986, The Journal of general virology.

[9]  J. Icenogle,et al.  Antigenic structure of polioviruses of serotypes 1, 2 and 3. , 1986, The Journal of general virology.

[10]  E. Wimmer,et al.  Synthesis of infectious poliovirus RNA by purified T7 RNA polymerase. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[11]  G. Schild,et al.  Construction of poliovirus intertypic recombinants by use of cDNA , 1986, Journal of virology.

[12]  D. Filman,et al.  Three-dimensional structure of poliovirus at 2.9 A resolution. , 1985, Science.

[13]  G. Schild,et al.  Induction by synthetic peptides of broadly reactive, type-specific neutralizing antibody to poliovirus type 3. , 1985, Virology.

[14]  S. J. Potter,et al.  Primary structure and gene organization of human hepatitis A virus. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[15]  F. Fraundorfer,et al.  Human rhinovirus 2: complete nucleotide sequence and proteolytic processing signals in the capsid protein region. , 1985, Nucleic acids research.

[16]  H. Fritz,et al.  The gapped duplex DNA approach to oligonucleotide-directed mutation construction. , 1984, Nucleic acids research.

[17]  R. Mountford,et al.  The complete nucleotide sequence of a common cold virus: human rhinovlrus 14 , 1984 .

[18]  E. Wimmer,et al.  Priming for and induction of anti-poliovirus neutralizing antibodies by synthetic peptides , 1983, Nature.

[19]  C. Wychowski,et al.  Localization of a poliovirus type 1 neutralization epitope in viral capsid polypeptide VP1. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[20]  B. Semler,et al.  Primary structure, gene organization and polypeptide expression of poliovirus RNA , 1981, Nature.

[21]  P. Ogra,et al.  Viral vaccination via the mucosal routes. , 1980, Reviews of infectious diseases.

[22]  F. Sanger,et al.  DNA sequencing with chain-terminating inhibitors. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[23]  B. Semler,et al.  Construction of a "mutagenesis cartridge" for poliovirus genome-linked viral protein: isolation and characterization of viable and nonviable mutants. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[24]  G. Schild,et al.  Neutralization epitopes on poliovirus type 3 particles: an analysis using monoclonal antibodies. , 1984, The Journal of general virology.

[25]  G. Schild,et al.  Monoclonal antibodies which block cellular receptors of poliovirus. , 1984, Virus research.

[26]  R. Mountford,et al.  The complete nucleotide sequence of a common cold virus: human rhinovirus 14. , 1984, Nucleic acids research.

[27]  Melnick Jl.  Poliomyelitis vaccines: an appraisal after 25 years. , 1980 .

[28]  A. Sabin,et al.  History of Sabin attenuated poliovirus oral live vaccine strains , 1973 .